DK168709B1 - Vektorer omfattende et gen, der koder for et primat-GM-CSF-protein, værtsceller transformeret med vektoren, fremgangsmåde til fremstilling af primat-GM-CSF-protein, og cDNA, der svarer til det CFS-kodende gen - Google Patents

Vektorer omfattende et gen, der koder for et primat-GM-CSF-protein, værtsceller transformeret med vektoren, fremgangsmåde til fremstilling af primat-GM-CSF-protein, og cDNA, der svarer til det CFS-kodende gen Download PDF

Info

Publication number
DK168709B1
DK168709B1 DK102886A DK102886A DK168709B1 DK 168709 B1 DK168709 B1 DK 168709B1 DK 102886 A DK102886 A DK 102886A DK 102886 A DK102886 A DK 102886A DK 168709 B1 DK168709 B1 DK 168709B1
Authority
DK
Denmark
Prior art keywords
csf
protein
cdna
cell
cells
Prior art date
Application number
DK102886A
Other languages
Danish (da)
English (en)
Other versions
DK102886D0 (da
DK102886A (da
Inventor
Steven C Clark
Gordon G Wong
Randal J Kaufman
Elizabeth A Wang
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27417446&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK168709(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK102886D0 publication Critical patent/DK102886D0/da
Publication of DK102886A publication Critical patent/DK102886A/da
Application granted granted Critical
Publication of DK168709B1 publication Critical patent/DK168709B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
DK102886A 1984-07-06 1986-03-06 Vektorer omfattende et gen, der koder for et primat-GM-CSF-protein, værtsceller transformeret med vektoren, fremgangsmåde til fremstilling af primat-GM-CSF-protein, og cDNA, der svarer til det CFS-kodende gen DK168709B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US62834284A 1984-07-06 1984-07-06
US62834284 1984-07-06
US65274284A 1984-09-19 1984-09-19
US65244784A 1984-09-19 1984-09-19
US65244784 1984-09-19
US65274284 1984-09-19
EP8500326 1985-07-04
PCT/EP1985/000326 WO1986000639A1 (en) 1984-07-06 1985-07-04 Lymphokine production and purification

Publications (3)

Publication Number Publication Date
DK102886D0 DK102886D0 (da) 1986-03-06
DK102886A DK102886A (da) 1986-03-06
DK168709B1 true DK168709B1 (da) 1994-05-24

Family

ID=27417446

Family Applications (2)

Application Number Title Priority Date Filing Date
DK102886A DK168709B1 (da) 1984-07-06 1986-03-06 Vektorer omfattende et gen, der koder for et primat-GM-CSF-protein, værtsceller transformeret med vektoren, fremgangsmåde til fremstilling af primat-GM-CSF-protein, og cDNA, der svarer til det CFS-kodende gen
DK199300594A DK172679B1 (da) 1984-07-06 1993-05-21 CSF-protein

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK199300594A DK172679B1 (da) 1984-07-06 1993-05-21 CSF-protein

Country Status (28)

Country Link
EP (2) EP0337359B1 (xx)
JP (4) JP2540509B2 (xx)
KR (1) KR910001809B1 (xx)
AT (2) ATE67244T1 (xx)
AU (3) AU599572B2 (xx)
CA (2) CA1341618C (xx)
CY (1) CY1629A (xx)
DE (3) DE3588199T2 (xx)
DK (2) DK168709B1 (xx)
ES (1) ES8701226A1 (xx)
FI (1) FI108796B (xx)
GR (1) GR851643B (xx)
HK (2) HK111594A (xx)
HU (1) HU208711B (xx)
IE (2) IE930961L (xx)
IL (2) IL75725A (xx)
LU (1) LU88337I2 (xx)
MY (1) MY102902A (xx)
NL (1) NL930089I2 (xx)
NO (4) NO179455C (xx)
NZ (2) NZ228031A (xx)
PL (1) PL153139B1 (xx)
PT (1) PT80776B (xx)
SA (1) SA94150015A (xx)
SG (1) SG108991G (xx)
SK (1) SK280265B6 (xx)
UA (1) UA39161C2 (xx)
WO (1) WO1986000639A1 (xx)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
KR920003822B1 (ko) * 1984-11-20 1992-05-15 쉐링 바이오텍 코포레이션 인체 과립구 대식 세포 및 호산성 세포 성장 인자 활성을 나타내는 폴리펩티드
DE3686794T2 (de) * 1985-02-05 1993-03-04 Cetus Oncology Corp Reinigung des natuerlichen kolonie-stimulierenden faktors-1.
ATE67517T1 (de) * 1985-09-30 1991-10-15 Chugai Pharmaceutical Co Ltd Menschlicher granulozyten-colony stimulierender faktor.
EP0238655A4 (en) * 1985-10-03 1989-09-11 Biogen Nv POLYPEPTIDES LIKE THE GRANULOCYTE-MACROPHOUS COLONY STIMULATION FACTORS (GM-CSF) AND THEIR METHODS OF PRODUCING LARGE QUANTITIES IN MICROBIAL CELLS.
CA1295567C (en) * 1988-07-25 1992-02-11 Lawrence T. Malek Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Factors that soak bone formation
GR871029B (en) 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
WO1988001297A1 (en) * 1986-08-11 1988-02-25 Cetus Corporation Expression of g-csf and muteins thereof
GB8624899D0 (en) * 1986-10-17 1986-11-19 Sandoz Ltd Monoclonal antibodies
JPH0618781B2 (ja) * 1986-10-18 1994-03-16 中外製薬株式会社 感染症治療剤
EP0276846A3 (en) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Colony-stimulating factor derivatives
JP2521094B2 (ja) * 1987-04-28 1996-07-31 アムジェン、インコーポレーテッド ヒト顆粒球マクロファ―ジコロニ―刺激因子をコ―ドする合成ｄｎａ、そのｄｎａを含むプラスミド、およびそのｄｎａで形質転換された大腸菌
WO1988010310A1 (en) * 1987-06-25 1988-12-29 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
US5391706A (en) * 1987-07-16 1995-02-21 Schering Plough Corporation Purification of GM-CSF
KR930007430B1 (ko) * 1987-07-16 1993-08-10 쉐링 코포레이션 크로마토그래피 단계에 의한 과립구-대식세포 콜로니-자극 인자의 정제방법
AU626530B2 (en) * 1987-07-17 1992-08-06 Schering Biotech Corporation Human granulocyte-macrophage colony stimulating factor and muteins thereof
IE63514B1 (en) * 1987-07-17 1995-05-03 Schering Biotech Corp Expression vectors for the production of human granulocyte-macrophage colony stimulation factor in a mammalian cell host
CA1317244C (en) * 1987-07-24 1993-05-04 Ernest Seigo Kawasaki Production of biologically active forms of csf using a baculovirus (acnpv)-insect cell expression system
WO1989011864A1 (en) * 1988-05-31 1989-12-14 Schering Biotech Corporation Method of treating myeloid leukemias
AU618283B2 (en) * 1988-10-10 1991-12-19 Instituto Nazionale Per Lo Studio E La Cura Dei Tumori The use of GM-CSF in the treatment of a patient requiring high-dose chemo- or radiotherapy for cancer
US5811523A (en) 1988-11-10 1998-09-22 Trinchieri; Giorgio Antibodies to natural killer stimulatory factor
JPH0322973A (ja) * 1989-01-19 1991-01-31 Wan Shen-Yuan ヒトヘパトーム細胞系によるコロニー形成促進因子（ＣＳＦｓ）の構成性産生
NZ234479A (en) * 1989-07-14 1992-03-26 Schering Corp Antagonists of gm-csf derived from the carboxyl terminus, antibodies, hybridomas and pharmaceutical compositions containing anti-idiotypic antibodies
ATE185815T1 (de) 1992-02-28 1999-11-15 Univ Texas Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen
US6004807A (en) * 1992-03-30 1999-12-21 Schering Corporation In vitro generation of human dendritic cells
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US7091319B1 (en) 1992-11-24 2006-08-15 Bauer S Christopher IL-3 variant hematopoiesis fusion protein
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6361977B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6413509B1 (en) 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
DE69433530T2 (de) 1993-05-12 2005-01-05 Genetics Institute, LLC, Cambridge Bmp-11 zusammensetzungen
DE69331268T2 (de) * 1993-06-30 2002-06-13 Lucky Ltd Modifizierte-Granulocyte-Makrophage-Kolonie-stimulierender-Faktor-Gen und seine Expression in Hefe
US6027919A (en) 1993-12-07 2000-02-22 Genetics Institute, Inc. BMP-12 and BMP-13 proteins and DNA encoding them
US5578301A (en) * 1993-12-14 1996-11-26 Sandoz Ltd. Method for using GM-CSF to reduce the acute phase response in a patient being administered IL-6 therapy
US5599536A (en) * 1993-12-13 1997-02-04 Sandoz Ltd. Method for suppressing the acute phase response in a patient receiving IL-6 therapy
US6165748A (en) 1997-07-11 2000-12-26 Genetics Institute, Inc. Frazzled nucleotide sequences and expression products
US6676937B1 (en) 1998-03-09 2004-01-13 Caritas St. Elizabeth's Medical Center Of Boston Inc. Compositions and methods for modulating vascularization
DE19905501B4 (de) 1999-02-10 2005-05-19 MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels
AU764681C (en) * 1999-02-12 2005-07-07 Washington University Stimulating neutrophil function to treat inflammatory bowel disease
US6869762B1 (en) 1999-12-10 2005-03-22 Whitehead Institute For Biomedical Research Crohn's disease-related polymorphisms
AU2258601A (en) * 1999-12-10 2001-06-18 Ellipsis Biotherapeutics Corporation Ibd-related polymorphisms
US6689599B1 (en) 2000-10-20 2004-02-10 Genetics Institute, Llc Aggrecanase molecules
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
US7125701B2 (en) 2001-07-27 2006-10-24 Wyeth Aggrecanase molecules
EP1476545A4 (en) 2002-01-31 2006-11-29 Wyeth Corp AGGRECANASEMOLEKÜLE
SG160194A1 (en) 2002-02-05 2010-04-29 Wyeth Corp Truncated aggrecanase molecules
JP2005534308A (ja) 2002-07-29 2005-11-17 ワイス 修飾ａｄａｍｔｓ４分子およびその使用法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428632A (en) * 1979-08-10 1984-01-31 Thomas & Betts Corporation Coaxial cable transition connector
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
DE188479T1 (de) 1987-05-21
NL930089I1 (nl) 1993-10-01
DK59493A (da) 1993-05-21
SK505985A3 (en) 1999-10-08
ATE172494T1 (de) 1998-11-15
FI860308A (fi) 1986-01-22
WO1986000639A1 (en) 1986-01-30
IE851695L (en) 1986-01-06
LU88337I2 (fr) 1994-05-04
PT80776B (pt) 1987-09-30
AU644359B2 (en) 1993-12-09
IL75725A0 (en) 1985-11-29
JPH06319557A (ja) 1994-11-22
AU628069B2 (en) 1992-09-10
DK172679B1 (da) 1999-05-17
NZ212645A (en) 1990-02-26
JP2540509B2 (ja) 1996-10-02
AU4545685A (en) 1986-02-10
NO943300L (no) 1986-03-13
NO943300D0 (no) 1994-09-07
AU4009089A (en) 1989-12-07
JP2594768B2 (ja) 1997-03-26
NO961452D0 (no) 1996-04-12
HK1011709A1 (en) 1999-07-16
IE60819B1 (en) 1994-08-10
PT80776A (en) 1985-08-01
NL930089I2 (nl) 1994-07-01
NZ228031A (en) 1991-12-23
PL254400A1 (en) 1986-06-17
PL153139B1 (en) 1991-03-29
HUT38675A (en) 1986-06-30
IL94754A0 (en) 1991-04-15
FI860308A0 (fi) 1986-01-22
ES8701226A1 (es) 1986-11-16
DK59493D0 (da) 1993-05-21
HK111594A (en) 1994-10-21
JPH06199897A (ja) 1994-07-19
NO179455C (no) 1996-10-09
ES544868A0 (es) 1986-11-16
IL75725A (en) 1993-02-21
DE3588199T2 (de) 1999-04-08
KR860700264A (ko) 1986-08-01
DE3584089D1 (de) 1991-10-17
EP0188479B1 (en) 1991-09-11
AU599572B2 (en) 1990-07-26
NO314941B1 (no) 2003-06-16
MY102902A (en) 1993-03-31
SA94150015B1 (ar) 2004-09-04
NO860775L (no) 1986-03-13
NO179455B (no) 1996-07-01
IE930961L (en) 1986-01-06
NO307348B1 (no) 2000-03-20
NO961452L (no) 1996-04-12
NO1996016I1 (no) 1996-12-18
KR910001809B1 (ko) 1991-03-26
EP0337359B1 (en) 1998-10-21
DK102886D0 (da) 1986-03-06
UA39161C2 (uk) 2001-06-15
DK102886A (da) 1986-03-06
EP0188479A1 (en) 1986-07-30
SG108991G (en) 1992-03-20
CY1629A (en) 1992-07-10
AU5497690A (en) 1990-09-13
JPH07163351A (ja) 1995-06-27
SK280265B6 (sk) 1999-10-08
SA94150015A (ar) 2005-12-03
DE3588199D1 (de) 1998-11-26
GR851643B (xx) 1985-11-26
ATE67244T1 (de) 1991-09-15
JP2594743B2 (ja) 1997-03-26
CA1341618C (en) 2011-07-19
JP2594744B2 (ja) 1997-03-26
HU208711B (en) 1993-12-28
CA1340852C (en) 1999-12-14
JPS61502682A (ja) 1986-11-20
EP0337359A3 (en) 1990-02-07
EP0337359A2 (en) 1989-10-18
FI108796B (fi) 2002-03-28

Similar Documents

Publication Publication Date Title
DK168709B1 (da) Vektorer omfattende et gen, der koder for et primat-GM-CSF-protein, værtsceller transformeret med vektoren, fremgangsmåde til fremstilling af primat-GM-CSF-protein, og cDNA, der svarer til det CFS-kodende gen
US5891429A (en) Recombinant human granulocyte-macrophage-colony stimulating factor (GM-CSF)
US4675285A (en) Method for identification and isolation of DNA encoding a desired protein
DK174598B1 (da) Glycosyleret eller ikke glycosyleret rekombinant polypeptid med aktivitet som human granulocyt/makrofag og eosinofil cellevækstfaktor, fremgangsmåde til fremstilling af polypeptidet, nucleotidsekvens kodende for polypeptidet, .....
US5942221A (en) Recombinant primate granulocyte macrophage-colony stimulating factor
HU205384B (en) Process for increased expressin of human interleukin-2 in mammal cells
JPH0657152B2 (ja) Ｃｓｆ遺伝子類
JPS6112288A (ja) 真核細胞の形質転換のための補助ｄｎａを含むベクタ−
JPH02195888A (ja) ヒトインターロイキン２活性を有するポリペプチドをコードする遺伝子を含有する組換えｄｎａ体および該組換えｄｎａ体により形質転換された原核生物細胞
CN114941012B (zh) 重组间充质干细胞及其应用
CN113957026B (zh) 一种用于生产重组人IL-1ra的工程菌株及制备方法和应用
EP0141779A1 (en) T-cell growth factor
CZ285023B6 (cs) Vektor zahrnující gen kódující bílkovinu GM-CSF primátů, hostitelská buňka, která je jím transformována, a způsob výroby bílkoviny GM-CSF primátů za jejího použití
JPH0692994A (ja) 新規ポリペプチド

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1994 00007, 940621

CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1994 00007, 940621

CTFG Supplementary protection certificate (spc) issued

Free format text: CA 1994 00007, 940621, EXPIRES: 20071023

PUP Patent expired